Skip to main content
Access Bio, Inc. logo

Access Bio, Inc. — Investor Relations & Filings

Ticker · 950130 ISIN · KR8840090003 LEI · 335800Q5TV77F4L9Q648 KO Manufacturing
Open in API
Filings indexed 247 across all filing types
Latest filing 2026-01-29 Director's Dealing
Country IN India
Listing KO 950130

About Access Bio, Inc.

https://accessbio.net/

Access Bio, Inc. is a company dedicated to the prevention and early diagnosis of infectious diseases through the research, development, and manufacturing of in vitro diagnostic solutions. Its portfolio includes rapid diagnostic tests (RDTs), immunochemical diagnostics, biosensors, and molecular diagnostic products. The company is recognized for commercializing high-quality tests to combat significant global health threats, including malaria, COVID-19, HIV, and HPV. With a large-scale manufacturing capacity, Access Bio distributes its products globally, serving as a key partner in global health, particularly in the fight against often-neglected diseases.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 1% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the share transactions (purchases) made by a director (Park Hee-deok) of Access Bio, Inc. This is a standard regulatory filing in South Korea for insider trading/director dealings, which corresponds to the 'Director's Dealing' category.
2026-01-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea. This type of filing is required when an entity or individual crosses a significant ownership threshold in a publicly traded company. According to the provided definitions, this falls under 'Major Shareholding Notification' (MRQ).
2026-01-29 Korean
타법인주식및출자증권취득결정
M&A Activity Classification · 1% confidence The document is a formal regulatory filing titled '타법인 주식 및 출자증권 취득결정' (Decision to Acquire Shares and Equity Securities of Another Corporation). It details the acquisition of RF Bio by Access Bio, including acquisition price, purpose, and financial summaries of the involved entities. This type of disclosure is a standard regulatory requirement for material corporate events, specifically M&A activity, and fits the 'M&A Activity' category.
2026-01-19 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 1% confidence The document is a formal regulatory filing submitted to the Financial Services Commission/Korea Exchange regarding the resignation of an outside director (사외이사). The title explicitly states '사외이사의 선임ㆍ해임 또는 중도퇴임에 관한 신고' (Report on the appointment, dismissal, or mid-term resignation of an outside director). This falls under the category of Board/Management Information as it pertains to changes in the company's board composition.
2025-12-17 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Regulatory Filings
2025-10-22 Korean
주식등의대량보유상황보고서(일반)
Regulatory Filings
2025-10-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.